Recipharm Expands Aseptic Filling Capabilities for Process Development and Clinical Supply
The system offers unmatched flexibility, featuring interchangeable modules that support various product types, such as syringes and vials.
Aseptic Filling | 11/02/2025 | By Aishwarya
Accord BioPharma Signs Exclusive US Licensing Deal with Bio-Thera for BAT2506
BAT2506 is a proposed golimumab biosimilar developed by Bio-Thera. Golimumab, a human monoclonal antibody, inhibits the biological activity of tumor necrosis factor alpha (TNF-alpha).
Aseptic Filling | 11/02/2025 | By Aishwarya
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy